News/Press Releases

• .@AmerGeriatrics commends the @US_FDA for authorizing 2 #COVID19 vaccines & expresses its support for the @CDCgov #ACIP's recommendations on groups that should be prioritized for #vaccination in the U.S. https://bit.ly/3h6CiiG

New York (Dec. 21, 2020) —The American Geriatrics Society today commends the U.S. Food and Drug Administration for its speedy, but thorough and transparent emergency use authorization of two COVID-19 vaccines and expresses its support for the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendations on groups that should be prioritized for vaccination in the initial phases of the U.S. COVID-19 vaccination program.

“An independent expert advisory board, FDA officials, and members of the ACIP have now vetted the available data for both the Pfizer and Moderna vaccines, and the AGS trusts the science behind them. We are happy to note that adults ages 65 and older comprised at least 21 percent of participants in Phase 3 clinical trials, and both vaccines demonstrated at least 86.5 percent efficacy in that age group,” said AGS President Annette Medina-Walpole, MD, AGSF.  “Based on these results, we encourage older adults to get vaccinated when the vaccine becomes available to them.” 

• .@AmerGeriatrics stands with the Council of Medical Specialty Societies (@CMSSmed) in condemning Trump’s false claim that physicians are inflating the #COVID19 death toll for financial gain #geriatrics https://bit.ly/31KAohw

New York (Oct. 26, 2020) — With its more than 6,000 members continuing to care for older Americans affected by COVID-19 at the front-line of the nation’s pandemic response, the American Geriatrics Society (AGS) today stood in solidarity with the Council of Medical Special Societies (CMSS) in condemning President Trump’s baseless claim that hospitals and physicians are inflating the number of COVID-19 deaths for their own financial gain.

New York (Sept. 3, 2020)—In oral and written testimony delivered today to the National Academies of Science, Engineering, and Medicine (NASEM), the American Geriatrics Society (AGS) stressed the importance of prioritizing health professionals and older adults in the distribution of a future COVID-19 vaccine. Delivered in response to an NASEM draft framework for the equitable distribution of coronavirus immunizations, the comments also stressed the importance of ensuring age is never used to exclude someone categorically from care, including prevention for a pandemic as pernicious as COVID-19.

New York (Aug. 14, 2020)—The American Geriatrics Society (AGS) today announced that Joseph G. Ouslander, MD, AGSF—a leading figure in geriatrics with decades of experience helming organizations like the AGS, its Health in Aging Foundation, and some of the nation’s most prestigious health institutions—will succeed William B. Applegate, MD, MPH, MACP, AGSF, as editor-in-chief of the Journal of the American Geriatrics Society (JAGS). Having already served in editorial leadership for JAGS across nearly three decades, Dr. Ouslander now will pilot one of the leading and only academic journals dedicated to the care we all need as we age, with Dr. Applegate’s tenure closing at the end of 2020. Dr. Applegate will remain active with the journal, serving as editor emeritus.

“Dr. Ouslander was unanimously endorsed for this position by the AGS Board of Directors,” noted AGS President Annie Medina-Walpole, MD, AGSF. “That speaks volumes not only about his prowess, but also about how highly regarded he is among his peers. We’re very fortunate to have Dr. Ouslander leading JAGS as we look to showcase a new decade of innovative research, care models, and education.”

New York (July 20, 2020)—The American Geriatrics Society (AGS) today expressed concern that the new process for sharing COVID-19 data risks fragile progress in our hard-fought national response to the pandemic. The AGS is particularly concerned that the new process, which would change the role of the Centers for Disease Control and Prevention (CDC), does not provide public access to the data at a time when the agency’s impartial expertise has never been needed more.

“Representing more than 6,000 experts who care for us all as we age, the AGS strongly believes the CDC is still best positioned to collect, analyze, and act on health data as we support age-friendly care in the face of pandemics,” notes AGS President Annie Medina-Walpole, MD, AGSF. “Instead of removing the country’s premier health protection agency from the equation, let’s focus on building the infrastructure it needs to remain ‘first among equals’ leading local, state, and other national partners in ending COVID-19.”